This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Aug 20;37(24):2095-2097.

doi: 10.1200/JCO.19.01113. Epub 2019 Jun 3.

Paying for CAR-T Therapy Amidst Limited Health System Resources

Jonathan D Campbell¹, Melanie D Whittington¹

Affiliations

PMID: 31157580
DOI: 10.1200/JCO.19.01113

Comment

Paying for CAR-T Therapy Amidst Limited Health System Resources

Jonathan D Campbell et al. J Clin Oncol. 2019.

. 2019 Aug 20;37(24):2095-2097.

doi: 10.1200/JCO.19.01113. Epub 2019 Jun 3.

Authors

Jonathan D Campbell¹, Melanie D Whittington¹

Affiliation

¹ 1University of Colorado Anschutz Medical Campus, Aurora, CO.

PMID: 31157580
DOI: 10.1200/JCO.19.01113

No abstract available

PubMed Disclaimer

Comment on

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma.
Lin JK, Muffly LS, Spinner MA, Barnes JI, Owens DK, Goldhaber-Fiebert JD. Lin JK, et al. J Clin Oncol. 2019 Aug 20;37(24):2105-2119. doi: 10.1200/JCO.18.02079. Epub 2019 Jun 3. J Clin Oncol. 2019. PMID: 31157579

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.